CRISPR in the Clinic
Type
Blog Post
Published
Nov. 2, 2023, 1:15 p.m.
...submissions to the UK, EU, and USA federal drug approval boards are being finalized, and it is very likely...limited to, ones targeting muscular dystrophy, cardiovascular disease, inflammatory diseases, blindness, ...primarily made in the liver. Similarly, for cardiovascular disease approaches targeting cholesterol, these...